ArticleFrontiers in cardiovascular medicine2025
Association between red blood cell distribution width-to-albumin ratio and in-hospital mortality in patients with congestive heart failure combined with chronic kidney disease.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Red cell distribution width-to-albumin ratio as a potential biomarker for short-term mortality risk in critically ill patients with cerebral hemorrhage: a retrospective study with dual-cohort validation.Frontiers in nutrition · 2026Article
- Correlation Between Red Blood Cell Distribution Width to Albumin Ratio and Cardiovascular Events in Maintenance Hemodialysis Patients.Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to explore the relationship between the blood cell distribution width-to-albumin ratio (RAR) and in-hospital mortality in patients with congestive heart failure (CHF) combined with chronic kidney disease (CKD). Methods: The patients' information was collected from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The association of the RAR and in-hospital mortality were assessed via logistic regression analysis with adjusting for different covariate, followed by visualization via the restricted cubic splines (RCS) analysis. Correlation analysis and machine learning algorithms were used to screen the clinical features associated with RAR. Mediation analysis was used to explore the function of RAR-related feature on their association. The receiver operating characteristic (ROC) curve and decision curve analysis (DCA) curves were used to explore the efficacy of RAR in predicting patient outcomes and the net clinical benefit, respectively. Results: A total of 1,243 patients were included in this study. Logistic regression analysis showed that RAR was a risk factor of in-hospital death. RCS showed a linear relationship between RAR and in-hospital mortality, which was not affected by confounding factors. Monocytes played a mediating role in the relationship between RAR and in-hospital mortality. RAR had a good efficacy and clinical net for predicting in-hospital mortality, half-year mortality, one-year mortality, and three-year mortality. Conclusions: We found that RAR was a risk factor for in-hospital death and could predict short-term and long-term outcomes in patients with CHF combined with CKD. Monocytes played a mediating role in their relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.